Physician profile
Robert K Chow
NPI 1184733024
$6,280.96
in general payments reported to CMS, 2019-2025
18 companies · $964 in 2025
The $964 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $324 · 2021: $1,115 · 2022: $1,073 · 2023: $969 · 2024: $945 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,754 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,754.31 |
| Education | $123.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,946.90 | 2019-2025 | Tremfya |
| Abbvie INC. | $1,212.28 | 2019-2025 | Skyrizi, Rinvoq |
| Amgen INC. | $837.85 | 2020-2025 | Otezla, Otezla |
| Lilly USA, LLC | $632.36 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $506.82 | 2019-2025 | |
| Genzyme Corporation | $359.97 | 2019-2025 | |
| Pfizer INC. | $185.04 | 2019-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $165.34 | 2019-2025 | Siliq |
| Leo Pharma INC. | $90.85 | 2019-2022 | |
| Ucb, INC. | $70.88 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $64.36 | 2022-2024 | Sotyktu |
| Celgene Corporation | $41.70 | 2019 | |
| Dermavant Sciences, INC. | $37.77 | 2023-2024 | Vtama |
| Prugen, INC. Pharmaceuticals | $35.04 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $27.72 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $25.71 | 2019-2020 | |
| Incyte Corporation | $22.99 | 2022 | |
| Sandoz INC. | $17.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.